Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 16,200 shares at $47.48 ($750K) on 2020-03-26, disclosed to the SEC on 2020-03-27.
Open-market sale of $750k TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.37 | 6,600 | $299K | 39.9% |
| 2 | $46.55 | 3,052 | $142K | 19.0% |
| 3 | $46.55 | 3,052 | $142K | 19.0% |
| 4 | $47.48 | 1,648 | $78K | 10.4% |
| 5 | $47.48 | 1,648 | $78K | 10.4% |
| 6 | $48.06 | 200 |
| $10K |
| 1.3% |
| Total | $46.28 avg | 16,200 | $750K | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |